PHASE-I TRIAL OF TRIMETREXATE GLUCURONATE ON A 5-DAY BOLUS SCHEDULE - CLINICAL-PHARMACOLOGY AND PHARMACODYNAMICS

被引：32

作者：

GROCHOW, LB

NOE, DA

DOLE, GB

ROWINSKY, EK

ETTINGER, DS

GRAHAM, ML

MCGUIRE, WP

DONEHOWER, RC

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1989年 / 81卷 / 02期

关键词：

D O I：

10.1093/jnci/81.2.124

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：124 / 130

页数：7

相关论文

共 20 条

[1]

BALIS FM, 1986, CANCER RES, V46, P169

[2] 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE (TMQ), A POTENT NON-CLASSICAL FOLATE ANTAGONIST INHIBITOR .1. EFFECT ON DIHYDROFOLATE-REDUCTASE AND GROWTH OF RODENT TUMORS INVITRO AND INVIVO [J].

BERTINO, JR ;

SAWICKI, WL ;

MOROSON, BA ;

CASHMORE, AR ;

ELSLAGER, EF .

BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) :1983-1987

[3]

BERTINO JR, 1987, NATL CANCER I MONOGR, V5, P87

[4]

CHABNER B, 1982, PHARM PRINCIPLES CAN, P236

[5]

DIDDENS H, 1983, CANCER RES, V43, P5286

[6]

DONEHOWER RC, 1985, P AN M AM SOC CLIN, V4, P32

[7]

DRAKE JC, 1985, CANCER TREAT REP, V69, P641

[8]

FANUCCHI MP, 1987, CANCER RES, V47, P3303

[9] ENZYMATIC ASSAYS FOR 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE, A PROMISING NEW NON-CLASSICAL ANTIFOLATE [J].

HEUSNER, JJ ;

MCCORMACK, JJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (07) :827-828

[10] CLINICAL-PHARMACOLOGY OF TRIMETREXATE [J].

HO, DHW ;

COVINGTON, WP ;

LEGHA, SS ;

NEWMAN, RA ;

KRAKOFF, IH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (03) :351-356